EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

World Media Directory · RSS · Email Newsletters

There were 1,773 press releases posted in the last 24 hours and 430,002 in the last 365 days.

Press Releases on February 13, 2024

1,607 Press Releases

Published on February 13, 2024 - 18:37 GMT

Verathon’s Handheld Video Laryngoscope, GlideScope Go 2, Now Certified for Stringent EMS Environments

Designed for Urgent and Critical Situations Where Every Second Counts BOTHELL, WA, UNITED STATES, February 13, 2024 /⁨EINPresswire.com⁩/ -- Verathon®, a global leader in airway management solutions, today announced that its latest innovation in handheld …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on February 13, 2024 - 18:37 GMT

Questions and Answers on how to use a CEP in the context of a Marketing Authorisation Application or a Marketing Authorisation ...

Questions and Answers (Q&A): how to use a CEP in the context of a Marketing Authorisation Application (MAA) or a Marketing Authorisation Variation (MAV) First published: 13/02/2024Reference Number: EMA/CHMP/CVMP/QWP/5/2024

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:37 GMT

Opinion/decision on a Paediatric investigation plan (PIP): COVID-19 Vaccine (inactivated, adjuvanted) Valneva, SARS-CoV-2 virus, ...

P/0018/2023 : EMA decision of 31 January 2023 on the acceptance of a modification of an agreed paediatric investigation plan for SARS-CoV-2 virus, beta-propiolactone inactivated adjuvanted with CpG 1018 (VLA2001) (COVID-19 Vaccine (inactivated, adjuvanted …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:37 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: P: decision agreeing on a ...

P/0028/2023 : EMA decision of 31 January 2023 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for satralizumab (Enspryng), (EMEA-001625-PIP04-22) AdoptedFirst published: 13/02/2024

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Status: ...

Two main studies were carried out to investigate whether MRI images made with Vueway were comparable to those made with another contrast agent, and better than those made without a contrast agent. One study involved 256 adults who had, or were highly …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Zerbaxa, Ceftolozane,tazobactam, decision type: PM: decision on the ...

P/0552/2022 : EMA decision of 4 January 2023 on the acceptance of a modification of an agreed paediatric investigation plan for ceftolozane / tazobactam (Zerbaxa), (EMEA-001142-PIP02-16-M01) First published: 13/02/2024

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

Human medicines European public assessment report (EPAR): Catiolanze, latanoprost, Date of authorisation: 15/11/2023, Revision: 1, ...

When pressure in the eye increases, it can cause damage to the retina (the light-sensitive membrane at the back of the eye) and to the optic nerve that sends signals from the eye to the brain. This can result in serious vision loss and even blindness. The …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

Human medicines European public assessment report (EPAR): Incruse Ellipta (previously Incruse), umeclidinium bromide, Date of ...

Incruse Ellipta was investigated in four main studies involving over 4,000 patients. Three studies compared Incruse Ellipta with placebo (a dummy treatment), while one study compared Incruse Ellipta with tiotropium (another medicine for COPD). The main …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of ...

Rolufta Ellipta was investigated in four main studies involving over 4,000 patients. Three studies compared Rolufta Ellipta with placebo (a dummy treatment), while one study compared Rolufta Ellipta with tiotropium (another medicine for COPD). The main …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

Human medicines European public assessment report (EPAR): Protopic, tacrolimus, Date of authorisation: 27/02/2002, Revision: 28, ...

Protopic should be prescribed by a doctor with experience in the diagnosis and treatment of atopic dermatitis. The ointment should be applied as a thin layer to the skin. When used for flare-ups, Protopic can be used for short-term and intermittent long- …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Date of authorisation: 03/08/2001, Revision: ...

Fabrazyme is used to treat patients who have Fabry disease, a rare inherited disorder. Patients with Fabry disease do not have enough of an enzyme called alpha-galactosidase A. This enzyme normally breaks down a fatty substance called globotriaosylceramide …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

Technical Webinar: Regulatory Procedure Management for PLM in IRIS for Network Users, Online, European Medicines Agency, Amsterdam,...

EMA is currently working on the onboarding of Regulatory Procedure Management (RPM) for Product Lifecycle Management (PLM) for medicinal products on IRIS. The 1st roll-out occurred on 23 January 2024, covering Variations, Article 61.3 Notifications, and …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

EMEA-003125-PIP02-21

P/0023/2023: EMA decision of 31 January 2023 on n the agreement of a paediatric investigation plan for avexitide (acetate) (EMEA-003125-PIP02-21) First published: 13/02/2024

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

Health technology assessment bodies

The European Medicines Agency (EMA) has been working closely with health technology assessment (HTA) bodies since 2008. Regional and national HTA bodies provide recommendations on medicines and other health technologies that can be financed or reimbursed …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:36 GMT

EMEA-003144-PIP01-21

Active Substance Asundexian Therapeutic area Cardiovascular diseases Decision number P/0021/2023 PIP number EMEA-003144-PIP01-21 Pharmaceutical form(s) Age-appropriate oral dosage form Film-coated tablet Condition(s) / indication(s) Prevention of arterial …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 13, 2024 - 18:35 GMT

eBase Solutions Completes SOC 2 Type 1 Security Compliance to Strengthen Customer Data Protection

TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- eBase Solutions (“eBase”) is thrilled to announce that it has successfully attained SOC 2 Type 1 security compliance, aligning with the rigorous criteria established by the American Institute of Certified Public …

Distribution channels: IT Industry, Media, Advertising & PR ...
Published on February 13, 2024 - 18:32 GMT

Microcatheter Market: Medtronic, Boston Scientific Leading the Way to a USD 1.2 Billion Market by 2030

The global microcatheter market is projected to reach a value of USD 1,236.8 Million by 2030, expanding at a notable CAGR of 5.2% between 2023 and 2030 PALO ALTO, UNITED STATES, CALIFORNIA, February 13, 2024 /⁨EINPresswire.com⁩/ -- The latest report by …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on February 13, 2024 - 18:31 GMT

Terrata Homes Continues Growth in Tampa Market with the Opening of Southern Hills

BROOKSVILLE, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) has announced further expansion of Terrata Homes into the Tampa market with the opening of Southern Hills, an incredible gated neighborhood in Brooksville, Florida. …

Distribution channels: Media, Advertising & PR, Real Estate & Property Management ...
Published on February 13, 2024 - 18:30 GMT

Purpose Healing Center Expands Detox Services in Scottsdale, Arizona and Accepts AHCCCS Insurance for Rehab Programs

Purpose Healing Center offers detox center services in Scottsdale and accepts AHCCCS insurance for rehab with the goal of accessibility for all in Arizona! SCOTTSDALE, ARIZONA, UNITED STATES, February 13, 2024 /⁨EINPresswire.com⁩/ -- Purpose Healing …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on February 13, 2024 - 18:29 GMT

Santa Clarita International Film Festival Opens Submissions for Its Highly Anticipated 2024 Film Season

LOS ANGELES, CA, UNITED STATES, February 13, 2024 /⁨EINPresswire.com⁩/ -- The Santa Clarita International Film Festival (SCIFF) is thrilled to announce the opening of submissions for its highly anticipated 2024 season. Filmmakers worldwide are invited to …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Previous 14 15 16 17 18 19 20 21 22 23 24 Next

Previous Day 2024 Calendar Next Day